A panel of four blood markers may help identify people with Sjögren’s disease, even those who lack common disease-associated…
Articles by Marisa Horak, MS
Amgen’s experimental therapy dazodalibep led to rapid, sustained reductions in disease activity among adults with moderate-to-severe Sjögren’s disease…
More than half of people with Sjögren’s disease have high levels of an inflammatory protein called interferon-alpha (IFN-alpha) and…
Innovent Biologics, a China-based biopharmaceutical company, is planning to launch a Phase 2 clinical trial testing its experimental therapy…
Through detailed computer-based analyses of publicly available genetic data sets, a team of scientists in China has identified three genes…
A global clinical trial testing Immunovant’s injection therapy IMVT-1402 against a placebo in adults with Sjögren’s disease is…
People with Sjögren’s disease don’t only have to deal with eye and mouth dryness, but also a wide range…
Trinity Biotech, which specializes in diagnostic test kits, is partnering with the University at Buffalo, New York (UB) to…
People with primary Sjögren’s disease, particularly those with more severe illness, show significantly different patterns of alternative splicing — a…
People living with Sjögren’s disease often experience disabling symptoms that have a substantial impact on day-to-day life, even as…